Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-818-2 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Additional information
Bioconcentration testing is not a required test at this annual volume under REACH. Information on bioconcentration was developed for other regulatory regimes. In a feasibility study, MTDID 44430 could not be stably maintained using the static exposure system available to the contract research organization engaged for testing under GLP criteria. QSAR modeling using OASIS LMC Catalogic software gave estimated BCF values of 32 - 33. This QSAR has been validated and is applicable to the class of acrylates.
A substantial set of data on metabolism of acrylate esters exists in the mammalian toxicology literature. Acrylate esters readily cross the gastrointestinal mucosa, after which they are delivered directly to the liver. In addition, acrylate esters are readily absorbed by the mucosa of the respiratory tract of mammals. In inhalation exposure, 50-65% of an ethyl acrylate dose was absorbed by the upper respiratory tract rather than the lungs (1). Uptake of acrylates by the gills of aquatic organisms is likely to be at least as efficient as respiratory exposure in mammals.
Extensive uptake of acrylates by mammals is mitigated by favorable detoxification. Conversion of acrylates occurs via two pathways: by enzymatic hydrolysis of the ester bond (with the acid and alcohol catabolized by normal cellular pathways) or by Michael 1,4-addition of the acrylic moiety to gluthatione (GSH) and other protein sulfhydryls (with the GSH-adduct converted enzymatically to a mercapturic acid adduct for urinary excretion) (1,2). Of the two, the hydrolytic pathway is most likely for MTDID 44430. The contribution of the glutathione pathway to overall metabolism of butyl acrylate was less than with ethyl acrylate (1.6-3.6% v. 11%, respectively) (3) or with methyl acrylate (6.6% of an interperitoneal dose) (4). Only 2% of 2-ethylhexyl acrylate labelled on the vinyl carbons was recovered as thioethers in the first 5 hours post-treatment (5). Mercapturic adducts of methyl methacrylate (2-methylacrylate) were not observed at all unless carboxylesterases were first inhibited by tri-o-tolyl phosphate, and methyl crotonate (3-methylacrylate) formed mercapturates at an intermediate level (4). Taken together, the results suggest that the glutathione reaction contributes less significantly to overall detoxification for sterically-hindered acrylates, or for acrylates with increasing molecular weight.
Transformation of acrylate esters is extremely rapid. In the study of 2-ethylhexyl acrylate, 50% of radioactivity was recovery as exhaled carbon dioxide in the first 24 hours (5). In a radiometric study of ethyl acrylate, approximately 60% of the total oral dose was recovered, mostly as carbon dioxide, within 9 hours (1). Approximately 50% of absorbed ethyl acrylate was hydrolyzed by esterases within the nasal mucosa before entering the general circulation (1). The remaining intact ethyl acrylate was hydrolyzed by esterase activity distributed throughout the body. Isolated rat liver homogenates were able to hydrolyze ethyl acrylate with an estimated half-life of two seconds, and lung homogenates had similar Km and Vmax values (2). The hydrolysis products, acrylic acid and an alcohol, are metabolized by normal cellular metabolism: the propionate cycle in the case of acrylic acid and beta-oxidation for the alcohol. In general, mammals tend to have a metabolic capacity/rate one order of magnitude higher than fish (6). However, given the rapidity with which mammals detoxify and eliminate acrylate esters, metabolism in fish is also likely to control bioaccumulation. Therefore, due to predicted rapid detoxification and elimination, it should be unnecessary to conduct additional bioconcentration tests with fish.
References:
1) J.E. McLaughlin, R.C. Baldwin, and J.M. Smith. Ethyl acrylate health affects assessment. In, Health Effect Assessments of the Basic Acrylates, T.R. Tyler, S. R. Murphy, E. K. Hunt, eds. CRC Press, 1994
2) C.B. Frederick, D.W. Potter, M. I. Chang-Mateu, and M.E. Andersen. A physiologically based pharmacokinetic and pharmacodynamic model to describe the oral dosing of rats with ethyl acrylate and its implications for risk assessment. Toxicol. Appl. Pharmacol. 1992 Vol. 114, pp. 246-260.
3) I. Linhart, M. Vosmanská and J. Šmejkal. Biotransformation of acrylates. Excretion of mercapturic acids and changes in urinary carboxylic acid profile in rat dosed with ethyl and 1-butyl acrylate. Xenobiotica 1994, Vol. 24, No. 10, pp. 1043-1052.
4) L. P. C. Delbressine, F. Seutter-Berlage, and E. Seutter. Identification of urinary mercapturic acids formed from acrylate, methacrylate and crotonate in the rat. Xenobiotica, 1981, Vol. 11, No. 4, pp. 241-247.
5) I. Gut, P. Vodička, M. Cikrt, A Sapota, I Kavan. Distribution and elimination of (14C)-2-ethylhexyl acrylate radioactivity in rats. Arch. Toxicol. 1988, Vol. 62, No. 5, pp. 346-50.
6) European Chemicals Agency . 2008. Guidance on information requirements and chemical safety assessment: Chapter R.7c: Endpoint specific guidance.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.